BD (Becton, Dickinson and Company) acquired Sirigen Group, a developer of polymer dyes that are used in flow cytometry and can be applied to other technologies.

According to the company, Sirigen’s polymer technology is based on Nobel Prize-winning research in conductive plastics and creates the potential for the development of novel dyes that are four to ten times brighter than conventional dyes.

“This new technology is a natural complement to our instrument platforms and reagent portfolio,” said Alberto Mas, president, BD Biosciences. “We believe that the acquisition will enable us to develop a continuous cadence of novel, unique dyes and antibody specificity releases over the next two years, significantly expanding our life science research reagent portfolio with high-impact products.”

The financial terms of the acquisition were not disclosed.








This site uses Akismet to reduce spam. Learn how your comment data is processed.